The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) OCF Margin %: 0.00% (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT318.20
View Full Analysis

What is The IBN SINA Pharmaceutical Industry OCF Margin %?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.47% 20 OCF Margin % is 0.00% as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100. Among 959 Drug Manufacturers companies, The IBN SINA Pharmaceutical Industry ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. The IBN SINA Pharmaceutical Industry's Cash Flow from Operations for the six months ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, The IBN SINA Pharmaceutical Industry's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, The IBN SINA Pharmaceutical Industry's current OCF Yield % is 0.00%.

The historical rank and industry rank for The IBN SINA Pharmaceutical Industry's OCF Margin % or its related term are showing as below:


DHA:IBNSINA's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.94
* Ranked among companies with meaningful OCF Margin % only.

The IBN SINA Pharmaceutical Industry OCF Margin % Related Terms

The IBN SINA Pharmaceutical Industry OCF Margin % Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry OCF Margin % Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
OCF Margin %

The IBN SINA Pharmaceutical Industry Semi-Annual Data
OCF Margin %
DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

The IBN SINA Pharmaceutical Industry's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

The IBN SINA Pharmaceutical Industry's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. According to the industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 959 companies in the Drug Manufacturers industry.
Is The IBN SINA Pharmaceutical Industry's OCF Margin % too high?
The IBN SINA Pharmaceutical Industry's current OCF Margin % is 0.00%. Based on the distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's OCF Margin % compare to IMNPQ?
According to the Drug Manufacturers industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 959 companies for OCF Margin %. This places The IBN SINA Pharmaceutical Industry in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The IBN SINA Pharmaceutical Industry's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT318.20
Price